GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of IMRX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Immuneering Corporation stock upgraded from Strong Sell Candidate to Sell Candidate after Wednesday trading session.
(Updated on Apr 17, 2024)

Sell candidate since Mar 11, 2024 Loss -68.66% PDF

The Immuneering Corporation stock price gained 1.09% on the last trading day (Wednesday, 17th Apr 2024), rising from $1.84 to $1.86. During the last trading day the stock fluctuated 8.09% from a day low at $1.82 to a day high of $1.97. The price has fallen in 6 of the last 10 days and is down by -22.5% for this period. Volume fell on the last day by -392 thousand shares and in total, 294 thousand shares were bought and sold for approximately $546.13 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.75 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -55.61% during the next 3 months and, with a 90% probability hold a price between $0.779 and $1.89 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

IMRX Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, April 16, 2024, and so far it has risen 1.09%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Immuneering Corporation stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.00 and $3.57. A break-up above any of these levels will issue buy signals. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for Immuneering Corporation stock

Immuneering Corporation finds support from accumulated volume at $1.84 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.147 between high and low, or 8.09%. For the last week the stock has had daily average volatility of 8.85%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (IMRX) For The Upcoming Trading Day Of Thursday 18th

For the upcoming trading day on Thursday, 18th we expect Immuneering Corporation to open at $1.88, and during the day (based on 14 day Average True Range), to move between $1.52 and $2.20, which gives a possible trading interval of +/-$0.337 (+/-18.10%) up or down from last closing price. If Immuneering Corporation takes out the full calculated possible swing range there will be an estimated 36.20% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.84 (1.08%) than the resistance at $1.91 (2.69%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Immuneering Corporation stock A Buy?

Immuneering Corporation holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -3.681 Sell Candidate Upgraded

Predicted Opening Price for Immuneering Corporation of Thursday, April 18, 2024

Fair opening price April 18, 2024 Current price
$1.88 ( 1.30%) $1.86

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for IMRX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.03 9.23 %
R2 1.98 6.20 %
R1 1.94 4.33 %
Current price: 1.86
Support S1 1.83 -1.73 %
S2 1.79 -3.60 %
S3 1.74 -6.62 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.19 17.74 %
R2 2.01 8.06 %
R1 1.91 2.69 %
Current price 1.86
Support S1 1.84 -1.08%
S2 0 .
S3 0 .

FAQ

What is the symbol for Immuneering Corporation Stock and on which exchange is it traded?
The symbol for Immuneering Corporation is IMRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Immuneering Corporation Stock?
Immuneering Corporation holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

How to buy Immuneering Corporation Stock?
Immuneering Corporation Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Immuneering Corporation Stock.

What's the current price of Immuneering Corporation Stock?
As of the end of day on the 2024-04-17, the price of an Immuneering Corporation (IMRX) share was $1.86.

What is the 52-week high and low for Immuneering Corporation Stock?
The 52-week high for Immuneering Corporation Stock is $14.29 and the 52-week low is $1.76.

What is the market capitalization of Immuneering Corporation Stock?
As of the 2024-04-17, the market capitalization of Immuneering Corporation is 54.467M.

When is the next earnings date for Immuneering Corporation?
The upcoming earnings date for Immuneering Corporation is May 02, 2024.
Click to get the best stock tips daily for free!

About Immuneering Corporation

Immuneering Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to treat solid tumors. The company also has five oncology programs in the discovery stage that are designed ... IMRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT